Clinical Trials
13 trialsNCT06651970 2026-05-18
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
Phase 4 Recruiting
NCT07029503 2026-02-24
SCARF-1
Karolinska Institutet
Phase 2 Recruiting
NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
NCT03746392 2025-08-22
PICSI-P
University of Washington
Phase NA Completed
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT05034354 2025-01-31
Virtual Remote Physiological Monitoring Program of Children With Heart Disease
University of Alberta
Phase NA Completed
NCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT05892146 2023-06-07
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
Phase NA Unknown
NCT03850171 2023-02-27
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
Phase NA Terminated
NCT02537769 2021-02-23
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
University of Washington
Phase NA Recruiting
NCT00195897 2016-08-22
Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)
Centre Henri Becquerel
Terminated